EvolveImmune Therapeutics Holding Co LLC

04/24/2026 | Press release | Distributed by Public on 04/24/2026 17:03

Pharmacological Integration of CD3 and CD2 Signaling Triggers Formation of a CD2 Corolla that Boosts T Cell Activation (EVOLVE triggers CD2 corolla synapse formation 5594 AACR2026)

EvolveImmune Therapeutics Holding Co LLC published this content on April 24, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 24, 2026 at 23:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]